Market Place
Sourcing Support
Ascletis Selects ASC37: First Oral Triple Agonist
30 Nov 2025 //
PR NEWSWIRE
Novo Nordisk Cuts Wegovy Prices, Generic Firms Adjust Pricing
27 Nov 2025 //
ECONOMICTIMES
Novo Reports 2 Trial Failures For GLP-1 In Alzheimer`s Disease
24 Nov 2025 //
GLOBENEWSWIRE
Biogen`s Leqembi Rises After Novo GLP-1 Fails In Alzheimer`s
24 Nov 2025 //
BIOSPACE
India Considers Global Tenders For Key Patented Drugs Due
23 Nov 2025 //
ECONOMICTIMES
Semaglutide Compounder Drops Claims After Novo Nordisk Challenge
21 Nov 2025 //
FIERCE PHARMA
Xevant Expands Ivim At Work, Lowers Wegovy And Ozempic Prices
20 Nov 2025 //
BUSINESSWIRE
Novo Nordisk India Focuses On Patient Outcomes, Revenue Growth
19 Nov 2025 //
ECONOMICTIMES
Eli Lilly, Novo Nordisk Strategize To Defend Top Obesity Drugs
18 Nov 2025 //
ECONOMICTIMES
Vanda Tackles Wegovy-Driven Vomiting, Sparking Race To Ph. 3
18 Nov 2025 //
FIERCE BIOTECH
GoodRx Launches $39/Month Weight Loss Telehealth Plan
17 Nov 2025 //
BUSINESSWIRE
Mangoceuticals Partners with Eli Lilly and Novo Nordisk
13 Nov 2025 //
GLOBENEWSWIRE
Mangoceuticals Clarifies Launch of Branded GLP-1 Programs
13 Nov 2025 //
GLOBENEWSWIRE
Vivani Medical Updates Business And Reveals Q3 2025 Financials
13 Nov 2025 //
GLOBENEWSWIRE
Novo Nordisk Reduces Wegovy Price By 33% In India
11 Nov 2025 //
ECONOMICTIMES
Emcure Partners With Novo To Increase Access To Wegovy In India
11 Nov 2025 //
BUSINESS STD
Camurus Reveals Positive Topline Data For CAM2056, Semaglutide
10 Nov 2025 //
PR NEWSWIRE
ACTG Reveals SLIM LIVER Results Showing Cardiovascular Risk
10 Nov 2025 //
GLOBENEWSWIRE
Wegovy Showed Liver Health Benefits In MASH Beyond Weight Loss
10 Nov 2025 //
PR NEWSWIRE
FDA Grants Priority Review Vouchers To Wegovy & Casgevy
08 Nov 2025 //
BIOSPACE
Novo Nordisk, Fangzhou Initiate AI Diabetes, Weight Management
07 Nov 2025 //
GLOBENEWSWIRE
Novo Nordisk`s Cagrisema Reduces Blood Pressure
06 Nov 2025 //
PR NEWSWIRE
Novo, Lilly strike Deal with Trump to Slash Drug Price
06 Nov 2025 //
REUTERS
Novo Nordisk Agrees With U.S. Administration To Expand Access
06 Nov 2025 //
GLOBENEWSWIRE
Skye Bioscience To Spotlight Rebound Weight Gain Improvement
05 Nov 2025 //
GLOBENEWSWIRE
NextPlat Secures Multi-State Rx Contract from DevotedDOC
05 Nov 2025 //
PR NEWSWIRE
Biomea Fusion Highlights Preclinical Progress Of BMF-650
05 Nov 2025 //
GLOBENEWSWIRE
Novo Wegovy Users Hit Waist & BMI Targets Linked To Health
05 Nov 2025 //
GLOBENEWSWIRE
Needles, Pens & Pressure: The GLP-1 Challenge
05 Nov 2025 //
EXPRESSPHARMA
India Strategic Launchpad For Next Wave Of Obesity Care
05 Nov 2025 //
ECONOMICTIMES
Wave Life Sciences Showcases WVE-007 Preclinical Data
04 Nov 2025 //
GLOBENEWSWIRE
Phenomix Expands Evidence for MyPhenome Test on GLP-1 Response
04 Nov 2025 //
PR NEWSWIRE
Veru to Present Two Abstracts at Obesityweek 2025
31 Oct 2025 //
GLOBENEWSWIRE
Rani to Present Oral Semaglutide Data via RaniPill at ObesityWeek
30 Oct 2025 //
GLOBENEWSWIRE
Biomea Fusion To Present Poster Presentations At Obesityweek 2025
30 Oct 2025 //
GLOBENEWSWIRE
Novo Nordisk to Unveil Wegovy 2.4mg Data at AASLD Meeting
28 Oct 2025 //
PR NEWSWIRE
Neumora Therapeutics Shows Superior Weight Loss With NMRA-215
27 Oct 2025 //
GLOBENEWSWIRE
Innovent`s Mazdutide Outperforms Semaglutide In Glycemic Control
27 Oct 2025 //
PR NEWSWIRE
Dr Reddy`s Gets Nod To Make Generic Semaglutide For Weight Loss
24 Oct 2025 //
ECONOMICTIMES
Ventyx`s CV Drug Rapidly Reduces Cardio Risk Biomarker
23 Oct 2025 //
FIERCE BIOTECH
Ventyx Biosciences Reports Positive Phase 2 Results For VTX3232
22 Oct 2025 //
GLOBENEWSWIRE
Novo`s Rybelsus Gains FDA Expansion To Reduce Risk Of MACE
21 Oct 2025 //
FIERCE PHARMA
Novo Nordisk To Unveil Oral Semaglutide 25mg Data at ObesityWeek
20 Oct 2025 //
PR NEWSWIRE
FDA Approves Novo`s oral semaglutide For Cardiovascular Risk
17 Oct 2025 //
PR NEWSWIRE
Novo, Lilly Shares Drop As Trump Promises $150 Ozempic
17 Oct 2025 //
BIOSPACE
Trump Says Price Of Ozempic Will Be Lowered
16 Oct 2025 //
REUTERS
Medvi Expands Telehealth Access To Oral GLP-1 Tablets
14 Oct 2025 //
GLOBENEWSWIRE
Resalis Report Fat-Selective Weight Loss With RES-010 In Primates
07 Oct 2025 //
GLOBENEWSWIRE
Skye Bioscience Reports Ph2a CBeyond Data For Nimacimab Therapy
06 Oct 2025 //
GLOBENEWSWIRE
Skye`s CB1 Blocker Fails To Reduce Weight In Obesity Study
06 Oct 2025 //
FIERCE BIOTECH
Aspire Bio To Present At Noble Capital Markets 2025 Growth Conf
03 Oct 2025 //
PHARMAWEB
European Doctors Recommend Novo And Lilly Weight-Loss Drugs
02 Oct 2025 //
ECONOMICTIMES
Forepass® Surpasses Semaglutide, Achieving 8X Weight Loss
01 Oct 2025 //
BUSINESSWIRE
Novo Nordisk Launches Ozempic In India, Boosting GLP-1 Market
01 Oct 2025 //
EXPRESSPHARMA
LIFMD Collaborates With Novo Nordisk, Offering Ozempic
30 Sep 2025 //
GLOBENEWSWIRE
Weight-Loss Drug Ozempic To Debut In India Soon
26 Sep 2025 //
ECONOMICTIMES
Innovent`s Weight-Loss Drug Highlights China Challenge for Novo
22 Sep 2025 //
REUTERS
Ascletis Reveal ASC47 with Semaglutide, 56.2% More Weight Loss
21 Sep 2025 //
PR NEWSWIRE
Indian API Makers Gear Up for Semaglutide Demand
20 Sep 2025 //
PRESS RELEASE
Europe`s CHMP Approves Novo`s Kyinsu, Bayer`s Lynkuet
19 Sep 2025 //
FIERCE PHARMA
